Oruka Therapeutics, Inc. · NASDAQ:ORKA
Fairmount Funds Management LLC reported a 19.99% stake in Oruka Therapeutics, Inc. (Schedule 13D/A)
Event Apr 30, 2026 · Filed May 4, 2026
Fairmount Funds Management LLC reported a 19.99% stake in Oruka Therapeutics, Inc., 13,665,080 shares, with active intent on Apr 30, 2026. Filed May 4, 2026 (Schedule 13D/A).
- Stake
- 19.99%
- Shares
- 13,665,080
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Fairmount Funds Management LLC | 19.99% | 13,665,080 |
| Fairmount Healthcare Fund II L.P. | 16.23% | 11,091,772 |
| Fairmount Healthcare Co-Invest III L.P. | 4.41% | 2,573,308 |
| Harwin Peter Evan | 19.99% | 13,660,663 |
| Kiselak Tomas | 19.99% | 13,665,080 |
Source
Related
- Oruka Therapeutics, Inc.
- Fairmount Funds Management LLC
- Oruka Therapeutics, Inc. shareholders
- Schedule 13D/A · Fairmount Funds Management LLC · Sep 19, 2025
- Schedule 13D/A · Fairmount Funds Management LLC · Mar 10, 2025
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026